学会発表ポスター
... accumulated action and is associated with a dose dependent-cardiotoxicity that can eventuate into heart failure. Dox-induced cardiotoxicity might be associated with inhibition of synthesis of DNA and RNA, generation of reactive oxygen species (ROS),direct membrane effects and so on. However, The mec ...
... accumulated action and is associated with a dose dependent-cardiotoxicity that can eventuate into heart failure. Dox-induced cardiotoxicity might be associated with inhibition of synthesis of DNA and RNA, generation of reactive oxygen species (ROS),direct membrane effects and so on. However, The mec ...
SVT
... Ventricular rhythm is usually irregularly irregular Average ventricular rate is 160 – 180 beats/min on no drugs No P waves seen QRS interval is usually normal (narrow) If see discrete P waves…think of MAT • This clinical scenario is a cardiac or pulmonary patient in the ICU. Thought to be due to a h ...
... Ventricular rhythm is usually irregularly irregular Average ventricular rate is 160 – 180 beats/min on no drugs No P waves seen QRS interval is usually normal (narrow) If see discrete P waves…think of MAT • This clinical scenario is a cardiac or pulmonary patient in the ICU. Thought to be due to a h ...
Aubrey Leatham and the introduction of cardiac pacing to the UK
... sister switched off the pacemaker device being used in an unfortunate woman patient, in order to let her die in peace. In order to reduce the pain associated with pacing Dr Leatham believed that he had to stimulate the heart directly and he decided to try the transvenous route to the right heart. Dr ...
... sister switched off the pacemaker device being used in an unfortunate woman patient, in order to let her die in peace. In order to reduce the pain associated with pacing Dr Leatham believed that he had to stimulate the heart directly and he decided to try the transvenous route to the right heart. Dr ...
new weapons for management of hyponatremia: vaptans
... trial studied 254 patients with class II or III CHF. The patients were randomized into four study groups to receive placebo, 30, 45, or 60 mg of tolvaptan daily for 25 days, while being maintained on furosemide, but not water restricted. The patients on all doses of the vasopressin antagonist lost w ...
... trial studied 254 patients with class II or III CHF. The patients were randomized into four study groups to receive placebo, 30, 45, or 60 mg of tolvaptan daily for 25 days, while being maintained on furosemide, but not water restricted. The patients on all doses of the vasopressin antagonist lost w ...
Health Canada Endorsed Important Safety Information on
... an increased risk of a composite endpoint of sudden cardiac death and serious ventricular arrhythmia, which was higher in patients older than 60 years of age (adjusted OR 1.64 ; 95% CI 1.31, 2.05). In this study, the composite endpoint of sudden cardiac death and serious ventricular arrhythmia consi ...
... an increased risk of a composite endpoint of sudden cardiac death and serious ventricular arrhythmia, which was higher in patients older than 60 years of age (adjusted OR 1.64 ; 95% CI 1.31, 2.05). In this study, the composite endpoint of sudden cardiac death and serious ventricular arrhythmia consi ...
Slide 1
... Yohannes AM, Doherty P, Bundy C,Yalfani A. The long-term benefits of cardiac rehabilitation on depression, anxiety, physical activity and quality of life. Journal of Clinical Nursing 2010; 19(19-20):2806-2813. ...
... Yohannes AM, Doherty P, Bundy C,Yalfani A. The long-term benefits of cardiac rehabilitation on depression, anxiety, physical activity and quality of life. Journal of Clinical Nursing 2010; 19(19-20):2806-2813. ...
Document
... therapeutic agent. Alone, it is effective at rate control as a first-line agent in only 58% of patients, which is comparable to calcium channel blockers but worse than beta blockers alone[8]. In combination, it can help reduce the dose of calcium channel blocker or beta blocker required to achieve ...
... therapeutic agent. Alone, it is effective at rate control as a first-line agent in only 58% of patients, which is comparable to calcium channel blockers but worse than beta blockers alone[8]. In combination, it can help reduce the dose of calcium channel blocker or beta blocker required to achieve ...
Case Study Oklahoma Heart Hospital: Clinician Leaders Establish Culture of Quality
... OK Heart has excelled in creating quality outcomes and generating patient satisfaction since it opened in 2002. High scores have been connected to positive financial performance: the hospital received the maximum payment from CMS for performance in evidencebased core measures and was recently select ...
... OK Heart has excelled in creating quality outcomes and generating patient satisfaction since it opened in 2002. High scores have been connected to positive financial performance: the hospital received the maximum payment from CMS for performance in evidencebased core measures and was recently select ...
Southwestern Illinois EMS System
... Heart as Pump • Cardiac output – Frank–Starling’s law • Greater the volume of blood in heart during diastole (preload), the more forceful cardiac contraction & more blood ventricle will pump (stroke volume) • Important that heart adjust its pumping capacity in response to changes in venous return • ...
... Heart as Pump • Cardiac output – Frank–Starling’s law • Greater the volume of blood in heart during diastole (preload), the more forceful cardiac contraction & more blood ventricle will pump (stroke volume) • Important that heart adjust its pumping capacity in response to changes in venous return • ...
Ventricular Fibrillation / Pulseless Ventricular Tachycardia
... After each intervention resume CPR immediately and reassess the rhythm after each 2 minute or 5 cycle interval. For Biphasic devices shock with energy levels following manufacturers’ recommendations (120 – 200 J). If unknown use the maximum available. For monophasic devices use 360 J. Pre-Medical Co ...
... After each intervention resume CPR immediately and reassess the rhythm after each 2 minute or 5 cycle interval. For Biphasic devices shock with energy levels following manufacturers’ recommendations (120 – 200 J). If unknown use the maximum available. For monophasic devices use 360 J. Pre-Medical Co ...
80-258-1-SP - International Journal of Health Studies
... Yang (2013) mentioned in their paper that “Cardiac self-efficacy is an important factor in initiating and maintaining health behaviors, which leads to a decreased recurrence of cardiac events and improved cardiac functions such as left ventricular EF in patients with CADs” (7). In a study conducted ...
... Yang (2013) mentioned in their paper that “Cardiac self-efficacy is an important factor in initiating and maintaining health behaviors, which leads to a decreased recurrence of cardiac events and improved cardiac functions such as left ventricular EF in patients with CADs” (7). In a study conducted ...
extracorporeal membrane Oxygenation in Pediatric
... data collection for the purpose of this study was approved by the Institutional Review Board at the Wolfson Medical Center, and the need for informed consent was waived. Medical records were retrospectively reviewed (including hospital charts, operative reports, perfusion data and the pediatric inte ...
... data collection for the purpose of this study was approved by the Institutional Review Board at the Wolfson Medical Center, and the need for informed consent was waived. Medical records were retrospectively reviewed (including hospital charts, operative reports, perfusion data and the pediatric inte ...
Liver function tests in patients with acute heart failure
... renal axis and the term “cardiorenal syndrome” has been proposed to link cardiac dysfunction with the subsequent deterioration in renal function.2 The interactions between impaired hemodynamics, characterizing the early stage of AHF, with other key organs, have been rather poorly described. ...
... renal axis and the term “cardiorenal syndrome” has been proposed to link cardiac dysfunction with the subsequent deterioration in renal function.2 The interactions between impaired hemodynamics, characterizing the early stage of AHF, with other key organs, have been rather poorly described. ...
AICD - Healthy Living NT
... can be lifesaving can help decrease the stress and shock when a treatment is delivered by your AICD. Some people find it reassuring to know their AICD is always ready to do its job. It should not cause disruption to your everyday life or activities. ...
... can be lifesaving can help decrease the stress and shock when a treatment is delivered by your AICD. Some people find it reassuring to know their AICD is always ready to do its job. It should not cause disruption to your everyday life or activities. ...
Impact of Longitudinal Myocardial Deformation on the Prognosis of
... Longitudinal Shortening Indexes: peak systolic mitral velocity by TDI (Smitral), global-İ and peak SR by speckle tracking averaged 5±2 cm/sec (range, 1-9), -8±3 % (range, -18 to -2), and -0.42±0.15 s-1 (range, -0.83 to -0.17), respectively. Correlation between LVEF and longitudinal myocardial contr ...
... Longitudinal Shortening Indexes: peak systolic mitral velocity by TDI (Smitral), global-İ and peak SR by speckle tracking averaged 5±2 cm/sec (range, 1-9), -8±3 % (range, -18 to -2), and -0.42±0.15 s-1 (range, -0.83 to -0.17), respectively. Correlation between LVEF and longitudinal myocardial contr ...
Treatment of Atrial Fibrillation: Evidence Favoring Rate Control
... agents, and the risk of proarrhythmia. Rate control may also be preferred in patients who are asymptomatic, lead a sedentary life, and are older. Ventricular rate control during AF is poorly defined. Rate control is believed to be adequate when the resting heart rate ranges between 60 and 80 beats/m ...
... agents, and the risk of proarrhythmia. Rate control may also be preferred in patients who are asymptomatic, lead a sedentary life, and are older. Ventricular rate control during AF is poorly defined. Rate control is believed to be adequate when the resting heart rate ranges between 60 and 80 beats/m ...
Ch 11 The Heart
... - Sinoatrial node – Pacemaker initiates contraction - Sequential stimulation occurs at other autorhythmic cells - Atrioventricular node - Atrioventricular bundle ...
... - Sinoatrial node – Pacemaker initiates contraction - Sequential stimulation occurs at other autorhythmic cells - Atrioventricular node - Atrioventricular bundle ...
8/09 LV Dyssnchrony and CRT
... Regional variance of strain (A) cannot differentiate identical variance of time to peak contraction between segments with delayed contraction clustered in 1 portion of the left ventricular wall (A, top), versus dispersion of delay through the heart (A, bottom); only the former displays dyssynchrony. ...
... Regional variance of strain (A) cannot differentiate identical variance of time to peak contraction between segments with delayed contraction clustered in 1 portion of the left ventricular wall (A, top), versus dispersion of delay through the heart (A, bottom); only the former displays dyssynchrony. ...
Document
... Lactation: Safety and efficacy have not been established in children. Not to be used in untreated phaeochromocytoma. ...
... Lactation: Safety and efficacy have not been established in children. Not to be used in untreated phaeochromocytoma. ...
Lecture 3 + 4 - Cardiac Cycle (2012).
... beat to the beginning of the next is called the cardiac cycle. Cardiac cycle is a complete beat of the heart. Each cycle is initiated by spontaneous generation of an action potential in the sinus node. The cardiac cycle consists of a period of relaxation called ...
... beat to the beginning of the next is called the cardiac cycle. Cardiac cycle is a complete beat of the heart. Each cycle is initiated by spontaneous generation of an action potential in the sinus node. The cardiac cycle consists of a period of relaxation called ...
2-9 VFib PulselessVT - Detroit East Medical Control Authority
... After each intervention resume CPR immediately and reassess the rhythm after each 2 minute or 5 cycle interval. For Biphasic devices shock with energy levels following manufacturers’ recommendations (120 – 200 J). If unknown use the maximum available. For monophasic devices use 360 J. Pre-Medical Co ...
... After each intervention resume CPR immediately and reassess the rhythm after each 2 minute or 5 cycle interval. For Biphasic devices shock with energy levels following manufacturers’ recommendations (120 – 200 J). If unknown use the maximum available. For monophasic devices use 360 J. Pre-Medical Co ...
Association of Low Paco2 with Central Sleep Apnea and
... $ The ratio of total sleep time to total dark time. studies, we speculate that the degree of periodic § P < 0.005 when means were compared. breathing with associated arterial oxyhemoglobin desaturation and arousals, if left untreated, may adversely affect cardiac function and result in excessive ten ...
... $ The ratio of total sleep time to total dark time. studies, we speculate that the degree of periodic § P < 0.005 when means were compared. breathing with associated arterial oxyhemoglobin desaturation and arousals, if left untreated, may adversely affect cardiac function and result in excessive ten ...
Physiology of Oculocardiac reflex
... Radial pulse was recorded. With lids closed the subject rotated, the eyeballs over the outer corner of his eyes using the index fingers, concentrating on the light between the eyebrows. The pulse was recorded again. ...
... Radial pulse was recorded. With lids closed the subject rotated, the eyeballs over the outer corner of his eyes using the index fingers, concentrating on the light between the eyebrows. The pulse was recorded again. ...
left ventricular mass index: a predictor of morbidity and mortality in
... ventricular mass index in the present study (p<0. 05). This finding is consistent with that reported by Gerdts et al13, who found a higher prevalence of increased left ventricular mass index in females (80%) as compared to males (70%). The duration of hypertension in patients with increased LVMI was ...
... ventricular mass index in the present study (p<0. 05). This finding is consistent with that reported by Gerdts et al13, who found a higher prevalence of increased left ventricular mass index in females (80%) as compared to males (70%). The duration of hypertension in patients with increased LVMI was ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.